$A Cashflow Statement | Understand Stock

$177.56 +$1.60 (0.91%) Live

$A Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Oct 31, 2025	FY2024 12 months to Oct 31, 2024	FY2023 12 months to Oct 31, 2023	FY2022 12 months to Oct 31, 2022	FY2021 12 months to Oct 31, 2021
Cash flows from operating activities:
Net Income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Share-based compensation
Deferred taxes expense (benefit)
Excess and obsolete inventory related charges
Net gain (loss) on equity securities
Asset impairment charges
Change in fair value of contingent consideration
Loss on extinguishment of debt
Net gain on Divestiture of Business
Resolution Bioscience, Inc.
Total net gain on Divestiture of Business
Other non-cash expense, net
Changes in assets and liabilities:
Accounts receivable, net
Inventory
Accounts payable
Employee compensation and benefits
Treasury lock agreement payment
Other assets and liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Proceeds from the sale of property, plant and equipment
Payments to acquire property, plant and equipment
Proceeds from the sale of equity securities
Payments to acquire equity securities
Proceeds from convertible note
Payment in exchange for convertible note
Payment to acquire intangible assets
Proceeds from Divestiture of Businesses
Resolution Bioscience, Inc.
Total proceeds from Divestiture of Businesses
Acquisitions of businesses and intangible assets, net of cash acquired
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from the issuance of common stock under employee stock plans
Payment of taxes related to net share settlement of equity awards
Payments for repurchase of common stock
Payment of excise taxes related to repurchases of common stock
Payment of dividends
Proceeds from Issuance of Long-Term Debt
Repayments of Long-Term Debt
Payments of debt issuance costs
Proceeds from commercial paper
Repayments of commercial paper
Repayments of finance leases
Purchase of noncontrolling Interests
Proceeds from credit facility and short-term loan
Repayments of debt and revolving credit facility
Net proceeds from (Repayments of ) Short-Term Debt
Payment for Contingent Consideration
Net cash used in financing activities

Effect of exchange rate movements
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Supplemental Cash Flow Information
Income Taxes Payments, Net of refunds received
Interest payments, net of capitalized interest
Net change in property, plant and equipment included in accounts payable and accrued liabilities-increase (decrease)
Property, Plant and Equipment
Total net change in property, plant and equipment included in accounts payable and accrued liabilities-increase (decrease)

Share Repurchase Program, Excise Tax, Payable

Comments